Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM

Keyphrases

• Japanese Patients 100%
• Subgroup Analysis 100%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Old Japanese 100%
• Ipragliflozin 100%
• STELLA 100%
• Elderly Patients 100%
• Non-elderly 100%
• Diabetes Subgroups 100%
• Adverse Drug Reaction 75%
• Body Mass Index 50%
• Serious Adverse Drug Reaction 50%
• Renal Disease 25%
• Clinical Application 25%
• Age Groups 25%
• Fasting Plasma Glucose 25%
• Glycated Hemoglobin 25%
• Post-marketing Surveillance 25%
• Pollakiuria 25%
• Polyuria 25%
• Clinical Trial Registry 25%
• Safety Concerns 25%
• Nonelderly Patients 25%
• Malignant Tumor 25%
• Hepatic Disease 25%
• Hypoglycemia 25%
• Skin Problems 25%
• Adverse-drug-reactions-incidence 25%
• Drug Effectiveness 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Drug Reaction 100%
• Ipragliflozin 100%
• Diabetes Mellitus 16%
• Malignant Neoplasm 16%
• Kidney Disease 16%
• Clinical Trial 16%
• Liver Disease 16%
• Glycosylated Hemoglobin 16%
• Postmarketing Surveillance 16%
• Pollakisuria 16%
• Polyuria 16%
• Hypoglycemia 16%